NEXMOS Revenue
Biotechnology Research • 
Korea, Republic of • 1-10 Employees
$
NEXMOS revenue & valuation
| Annual revenue | $7,500,000 |
| Revenue per employee | $1,875,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $24,000,000 |
| Total funding | No funding |
Key Contact at NEXMOS
Gyuyoup Kim
R&D Director
Company overview
| Headquarters | Korea, Republic of |
| Phone number | +827082206400 |
| Website | |
| SIC | 873 |
| Employees | 1-10 |
| Socials |
About NEXMOS
NEXMOS is a company that specializes in the development and production of dna aptamer biotechnology. They offer a platform that combines unique dna biotechnology with dna meta-platform aptamin to promote effective dna treatment and healthcare.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Director
Funding Data
NEXMOS has never raised funding before.
United Kingdom
Australia
United States
Canada
Frequently asked questions
NEXMOS is located in KR.
You can reach NEXMOS at +827082206400.
NEXMOS generates an estimated annual revenue of $7,500,000. This revenue figure reflects the company's market position and business performance in its industry.
NEXMOS has an estimated valuation of $24,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
NEXMOS has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
